Factors affecting platinum sensitivity in cervical cancer

about

Regulation of cytotoxicity and apoptosis-associated pathways contributes to the enhancement of efficacy of cisplatin by baicalein adjuvant in human A549 lung cancer cells.

P2860

Q33597807-E364DA0B-CA35-47B7-B330-C2075268DE4E

P2860

Factors affecting platinum sensitivity in cervical cancer

Item

http://www.wikidata.org/entity/Q36336472

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Factors affecting platinum sensitivity in cervical cancer

@ast

Factors affecting platinum sensitivity in cervical cancer

@en

type

Item

label

Factors affecting platinum sensitivity in cervical cancer

@ast

Factors affecting platinum sensitivity in cervical cancer

@en

prefLabel

Factors affecting platinum sensitivity in cervical cancer

@ast

Factors affecting platinum sensitivity in cervical cancer

@en

P1476

Factors affecting platinum sensitivity in cervical cancer

@en

P2093

Ichio Fukasawa

http://www.w3.org/2001/XMLSchema#string

Kiyoshi Hasegawa

http://www.w3.org/2001/XMLSchema#string

Rina Kato

http://www.w3.org/2001/XMLSchema#string

Yasuhiro Udagawa

http://www.w3.org/2001/XMLSchema#string

Yutaka Torii

http://www.w3.org/2001/XMLSchema#string

P2860

XRCC1 R399Q polymorphism is associated with response to platinum-based neoadjuvant chemotherapy in bulky cervical cancer.

DNA damage-induced activation of p53 by the checkpoint kinase Chk2

Enhanced phosphorylation of p53 by ATM in response to DNA damage

Phase III trial of four cisplatin-containing doublet combinations in stage IVB, recurrent, or persistent cervical carcinoma: a Gynecologic Oncology Group study.

DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy.

Gene expression of ERCC1 as a novel prognostic marker in advanced bladder cancer patients receiving cisplatin-based chemotherapy.

The role of chemotherapy in the management of carcinoma of the cervix.

Bcl-2 protein expression and long-term survival in breast cancer

Prognostic significance of the bcl-2 apoptotic family of proteins in primary and recurrent cervical cancer

Bcl-2 and the regulation of programmed cell death.

P304

3591-3598

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/OL.2015.3755

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-09-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

282349508

http://www.w3.org/2001/XMLSchema#string

P698

26788175

http://www.w3.org/2001/XMLSchema#string

P932

4665966

http://www.w3.org/2001/XMLSchema#string

Factors affecting platinum sensitivity in cervical cancer

about

P2860

P2860

Factors affecting platinum sensitivity in cervical cancer

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932